Published in Vaccine Weekly, June 8th, 2005
"T cells are crucial for the control of CMV in infected individuals. Although CMV-specific T cells can be quantified by various methods, clear correlates of protection from CMV disease have not been defined. However, responses to the pp65 protein are believed to play an important role," wrote T. Bunde and colleagues, University of Medicine Berlin.
"Here, the proportions of interferon gamma-producing T cells following ex vivo activation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-06-08)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.